4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004523
Chief Business Development Off sold 417 shares at $69.00 ($28,773)
- Chief Business Development Off acquired 417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Business Development Off
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-19 | Exercise or conversion : show line 1 in the form | +417 | $6.27 | $2,615 | 417 | D |
| 2021-01-19 | Sale : show line 2 in the form | −417 | $69.00 | $28,773 | 0 | D |
| Open-market sales · 417 sh · avg $69.00 · $28,773 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-19 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −417 | 1,250 | D |
Loading xslF345X03/doc4.xml…